The present invention relates generally to the monoclonal antibodies of identification CD47, relate more specifically to not cause the cell agglutination of significant level, erythrocyte to reduce, the CD47 antibody of anaemia and/or decrease of platelet, it is related to generating the method for these antibody, and is related to the method for using these monoclonal antibodies as therapeutic agent.本發明通常涉及識別CD47的單克隆抗體,更具體地涉及不導致顯著水平的細胞凝集、血紅細胞減少、貧血和/或血小板减少的CD47抗體,涉及生成這些抗體的方法,以及涉及使用這些單克隆抗體作爲治療劑的方法。